The Role of Major Facilitator Superfamily Domain-Containing 2a in the Central Nervous System

Alakbarzade V, Hameed A, Quek DQ, Chioza BA, Baple EL, Cazenave-Gassiot A, Nguyen LN, Wenk MR, Ahmad AQ, Sreekantan-Nair A, Weedon MN, Rich P, Patton MA, Warner TT, Silver DL, Crosby AH (2015) A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome. Nat Genet 47(7):814–817. https://doi.org/10.1038/ng.3313

Article  CAS  PubMed  Google Scholar 

Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik A, Ginty DD, Clish CB, Gu C (2017) Blood–brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron 94:581-594.e5. https://doi.org/10.1016/j.neuron.2017.03.043

Article  CAS  PubMed Central  PubMed  Google Scholar 

Angers M, Uldry M, Kong D, Gimble JM, Jetten AM (2008) Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis. Biochem J 416(3):347–355. https://doi.org/10.1042/BJ20080165

Article  CAS  PubMed  Google Scholar 

Balakrishnan J, Kannan S, Govindasamy A (2021) Structured form of DHA prevents neurodegenerative disorders: a better insight into the pathophysiology and the mechanism of DHA transport to the brain. Nutr Res 85:119–134. https://doi.org/10.1016/j.nutres.2020.12.003

Article  CAS  PubMed  Google Scholar 

Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, Gu C (2014) MFSD2A is critical for the formation and function of the blood–brain barrier. Nature 509(7501):507–511. https://doi.org/10.1038/nature13324

Article  CAS  PubMed Central  PubMed  Google Scholar 

Cater RJ, Chua GL, Erramilli SK, Keener JE, Choy BC, Tokarz P, Chin CF, Quek DQY, Kloss B, Pepe JG, Parisi G, Wong BH, Clarke OB, Marty MT, Kossiakoff AA, Khelashvili G, Silver DL, Mancia F (2021) Structural basis of omega-3 fatty acid transport across the blood–brain barrier. Nature 595(7866):315–319. https://doi.org/10.1038/s41586-021-03650-9

Article  CAS  PubMed Central  PubMed  Google Scholar 

Chen H, Tang X, Li J, Hu B, Yang W, Zhan M, Ma T, Xu S (2022) IL-17 crosses the blood–brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine. J Headache Pain 23(1):1. https://doi.org/10.1186/s10194-021-01374-9

Article  CAS  PubMed Central  PubMed  Google Scholar 

Colombo F, Falvella FS, Galvan A, Frullanti E, Kunitoh H, Ushijima T, Dragani TA (2011) A 5′-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A. Mol Cancer 10:81. https://doi.org/10.1186/1476-4598-10-81

Article  CAS  PubMed Central  PubMed  Google Scholar 

Cui Y, Wang Y, Song X, Ning H, Zhang Y, Teng Y, Wang J, Yang X (2021) Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood–brain barrier permeability. Cell Rep 36(1):109327. https://doi.org/10.1016/j.celrep.2021.109327

Article  CAS  PubMed  Google Scholar 

De Bock M, Van Haver V, Vandenbroucke RE, Decrock E, Wang N, Leybaert L (2016) Into rather unexplored terrain transcellular transport across the blood–brain barrier. Glia 64(7):1097–1123. https://doi.org/10.1002/glia.22960

Article  PubMed  Google Scholar 

DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V (2014) The role of the blood–brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci 8:302. https://doi.org/10.3389/fncel.2014.00302

Article  PubMed Central  PubMed  Google Scholar 

Eser Ocak P, Ocak U, Sherchan P, Gamdzyk M, Tang J, Zhang JH (2020a) Overexpression of Mfsd2a attenuates blood brain barrier dysfunction via Cav-1/Keap-1/Nrf-2/HO-1 pathway in a rat model of surgical brain injury. Exp Neurol 326:113203. https://doi.org/10.1016/j.expneurol.2020.113203

Article  CAS  PubMed  Google Scholar 

Eser Ocak P, Ocak U, Sherchan P, Zhang JH, Tang J (2020b) Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far? J Neurosci Res 98(1):29–41. https://doi.org/10.1002/jnr.24327

Article  CAS  PubMed  Google Scholar 

Freund LY, Vedin I, Cederholm T, Basun H, Faxén IG, Eriksdotter M, Hjorth E, Schultzberg M, Vessby B, Wahlund LO, Salem N, Palmblad J (2014) Transfer of omega-3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer’s disease: the Omeg AD study. J Intern Med 275(4):428–436. https://doi.org/10.1111/joim.12166

Article  CAS  Google Scholar 

Guemez-Gamboa A, Nguyen LN, Yang H, Zaki MS, Kara M, Ben-Omran T, Akizu N, Rosti RO, Rosti B, Scott E, Schroth J, Copeland B, Vaux KK, Cazenave-Gassiot A, Quek DQ, Wong BH, Tan BC, Wenk MR, Gunel M, Gabriel S, Chi NC, Silver DL, Gleeson JG (2015) Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. Nat Genet 47(7):809–813. https://doi.org/10.1038/ng.3311

Article  CAS  PubMed Central  PubMed  Google Scholar 

Harel T, Quek DQY, Wong BH, Cazenave-Gassiot A, Wenk MR, Fan H, Berger I, Shmueli D, Shaag A, Silver DL, Elpeleg O, Edvardson S (2018) Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination. Neurogenetics 19(4):227–235. https://doi.org/10.1007/s10048-018-0556-6

Article  PubMed  Google Scholar 

Ju X, Miao T, Chen H, Ni J, Han L (2021) Overcoming Mfsd2a-mediated low transcytosis to boost nanoparticle delivery to brain for chemotherapy of brain metastases. Adv Healthc Mater 10(9):e2001997. https://doi.org/10.1002/adhm.202001997

Article  CAS  PubMed  Google Scholar 

Kempińska W, Korta K, Marchaj M, Paprocka J (2022) Microcephaly in neurometabolic diseases. Children (basel). 9(1):97. https://doi.org/10.3390/children9010097

Article  PubMed Central  PubMed  Google Scholar 

Khuller K, Yigit G, Grijalva CM, Altmüller J, Thiele H, Nürnberg P et al (2021) MFSD2A-associated primary microcephaly—Expanding the clinical and mutational spectrum of this ultra-rare disease. Eur J Med Genet 64(10):104310. https://doi.org/10.1016/j.ejmg.2021.104310

Article  CAS  PubMed  Google Scholar 

Kim YS, Kim M, Choi SH, You SH, Yoo RE, Kang KM, Yun TJ, Lee ST, Moon J, Shin YW (2019) Altered vascular permeability in migraine-associated brain regions: evaluation with dynamic contrast-enhanced MRI. Radiology 292(3):713–720. https://doi.org/10.1148/radiol.2019182566

Article  PubMed  Google Scholar 

Kristofova M, Ori A, Wang ZQ (2022) Multifaceted microcephaly-related gene MCPH1. Cells 11(2):275. https://doi.org/10.3390/cells11020275

Article  CAS  PubMed Central  PubMed  Google Scholar 

Liang H, Chen J (2021) Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B 11(8):2306–2325. https://doi.org/10.1016/j.apsb.2020.11.023

Article  CAS  Google Scholar 

Matuszyk MM, Garwood CJ, Ferraiuolo L, Simpson JE, Staniforth RA, Wharton SB (2022) Biological and methodological complexities of beta-amyloid peptide: implications for Alzheimer’s disease research. J Neurochem 160(4):434–453. https://doi.org/10.1111/jnc.15538

Article  CAS  PubMed  Google Scholar 

Milanovic D, Petrovic S, Brkic M, Avramovic V, Perovic M, Ivkovic S, Glibetic M, Kanazir S (2018) Short-term fish oil treatment changes the composition of phospholipids while not affecting the expression of Mfsd2a omega-3 transporter in the brain and liver of the 5xFAD mouse model of Alzheimer’s disease. Nutrients 10(9):1250. https://doi.org/10.3390/nu10091250

Article  CAS  PubMed Central  PubMed  Google Scholar 

Naveed M, Kazmi SK, Amin M, Asif Z, Islam U, Shahid K, Tehreem S (2018) Comprehensive review on the molecular genetics of autosomal recessive primary microcephaly (MCPH). Genet Res (camb) 100:e7. https://doi.org/10.1017/S0016672318000046

Article  PubMed  Google Scholar 

Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh ELK, Silver DL (2014) Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509:503–506. https://doi.org/10.1038/nature13241

Article  CAS  PubMed  Google Scholar 

Park YH, Shin SJ, Kim HS, Hong SB, Kim S, Nam Y, Kim JJ, Lim K, Kim JS, Kim JI, Jeon SG, Moon M (2020) Omega-3 fatty acid-type docosahexaenoic acid protects against Aβ-mediated mitochondrial deficits and pathomechanisms in Alzheimer’s disease-related animal model. Int J Mol Sci 21(11):3879. https://doi.org/10.3390/ijms21113879

Article  CAS  PubMed Central  PubMed  Google Scholar 

Phan TP, Holland AJ (2021) Time is of the essence: the molecular mechanisms of primary microcephaly. Genes Dev 35:1551–1578. https://doi.org/10.1101/gad.348866.121

Article  CAS  PubMed Central  PubMed  Google Scholar 

Qu C, Song H, Shen J, Xu L, Li Y, Qu C, Li T, Zhang J (2020) Mfsd2a reverses spatial learning and memory impairment caused by chronic cerebral hypoperfusion via protection of the blood–brain barrier. Front Neurosci 14:461. https://doi.org/10.3389/fnins.2020.00461

Article  PubMed Central  PubMed  Google Scholar 

Razmara E, Azimi H, Tavasoli AR, Fallahi E, Sheida SV, Eidi M, Bitaraf A, Farjami Z, Daneshmand MA, Garshasbi M (2020) Novel neuroclinical findings of autosomal recessive primary microcephaly 15 in a consanguineous Iranian family. Eur J Med Genet 63(12):104096. https://doi.org/10.1016/j.ejmg.2020.104096

Article  PubMed  Google Scholar 

Sánchez-Campillo M, Ruiz-Palacios M, Ruiz-Alcaraz AJ, Prieto-Sánchez MT, Blanco-Carnero JE, Zornoza M, Ruiz-Pastor MJ, Demmelmair H, Sánchez-Solís M, Koletzko B, Larqué E (2020a) Child head circumference and placental MFSD2a expression are associated to the level of MFSD2a in maternal blood during pregnancy. Front Endocrinol (lausanne) 11:38. https://doi.org/10.3389/fendo.2020.00038

Article  PubMed  Google Scholar 

Sánchez-Campillo M, Ruiz-Pastor MJ, Gázquez A, Marín-Muñoz J, Noguera-Perea F, Ruiz-Alcaraz AJ, Manzanares-Sánchez S, Antúnez C, Larqué E (2020b) Decreased blood level of MFSD2a as a potential biomarker of Alzheimer’s disease. Int J Mol Sci 21(1):70. https://doi.org/10.3390/ijms21010070

Article  CAS 

留言 (0)

沒有登入
gif